Karyopharm Therapeutics Inc. — Form D

Karyopharm Therapeutics Inc. of NEWTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-05-01. The offering totals $60.0M, of which $20.5M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Alan BarberExecutive OfficerWellesley, MA
Sharon ShachamExecutive OfficerTEL AVIV, L3
Paul BrannellyExecutive OfficerCambridge, MA
Peter G HonigDirectorNewton, MA
Barry E GreeneDirectorNewton, MA
Stuart PoultonExecutive OfficerNewton, MA
Michael ManoExecutive OfficerNewton, MA
Reshma RangwalaExecutive OfficerNewton, MA
Richard PaulsonDirectorNewton, MA
Richard PaulsonExecutive OfficerNewton, MA
Chen R SchorDirectorNewton, MA
Stephen MitchenerExecutive OfficerNewton, MA
Michael MasonExecutive OfficerNewton, MA
Mansoor Raza MirzaDirectorNewton, MA
Garen G BohlinDirectorNewton, MA
Christy J OligerDirectorNewton, MA
Sohanya ChengExecutive OfficerNewton, MA
MICHAEL KAUFFMANDirectorNEEDHAM, MA
MICHAEL KAUFFMANExecutive OfficerNEEDHAM, MA
Deepika R PakianathanDirectorMountain View, CA
Barry Raza GreeneDirectorNatick, MA
Deepika E PakianathanDirectorNatick, MA
Sharon E ShachamExecutive OfficerNatick, MA
Kenneth E WegDirectorNatick, MA
Ronald DePinhoDirectorCambridge, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2022-12-08D$165.0M$165.0M
2013-08-01D$19.0M$19.0M
2010-11-05D$20.8M$700K

More